title: The Ontogeny and Population Variability of Human Hepatic NADPH Dehydrogenase Quinone Oxido-Reductase 1 (NQO1).
abstract: The NADPH dehydrogenase quinone oxido-reductase 1 (NQO1) enzyme is an antioxidant and metabolic enzyme that performs two electron reduction of quinones and other chemicals. Based on the physiologic role(s) of NQO1, we hypothesized that expression and activity of this enzyme would vary with age and other demographic variables. Cytosols from 117 archived human livers were investigated for changes in NQO1 with age, sex, obesity, and ethnicity. Protein expression but not activity of NQO1 was weakly negatively correlated with age (Spearman r = -0.2, P = 0.03). No sex differences were observed for either protein expression or activity and for ethnicity; Caucasians had greater NQO1 activity than Asians (P < 0.05). Overweight children had statistically significantly higher NQO1 activity as compared with ideal weight children (P < 0.05) although this difference was not observed in adults. These findings establish that NQO1 is approximately as active in children as adults. However, modeled NQO1 clearance (both allometric and physiologically based pharmacokinetics) predicted maturation at 23 to 26 years. This is almost certainly an overestimate, with error in the model resulting from a small sample size and inability to scale for age-related changes in hepatic cellularity and/or cytosolic protein content, and indicates a delay in reaching maximum clearance through the NQO1 pathway that is affected by physiologic development as much, or more than, biochemical development. Obesity may increase hepatic NQO1 activity in children, which is likely a protective mechanism in oxidative stress, but may also have significant implications for drug and chemical disposition in obese children.
authors: Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii (L.R.A.R., A.C.C.); Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada (Z.R., J.M.B., A.C.C.).
authors: Luc R A
authors: LR
authors: Rougée
authors: Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii (L.R.A.R., A.C.C.); Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada (Z.R., J.M.B., A.C.C.).
authors: Zoe
authors: Z
authors: Riches
authors: Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii (L.R.A.R., A.C.C.); Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada (Z.R., J.M.B., A.C.C.).
authors: Jacob M
authors: JM
authors: Berman
authors: Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii (L.R.A.R., A.C.C.); Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada (Z.R., J.M.B., A.C.C.) abby.collier@ubc.ca.
authors: Abby C
authors: AC
authors: Collier
mesh_terms: D015086:2,6-Dichloroindophenol / Q000493:pharmacokinetics*; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000208:ethnology / Q000378:metabolism*; D044466:Asian People; D002648:Child; D002675:Child, Preschool; D003600:Cytosol / Q000201:enzymology; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008099:Liver / Q000201:enzymology*; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D016660:NAD(P)H Dehydrogenase (Quinone) / Q000378:metabolism*; D063766:Pediatric Obesity / Q000201:enzymology; D012737:Sex Factors; D013379:Substrate Specificity; D044465:White People; D055815:Young Adult
chemical_list: D015086:2,6-Dichloroindophenol; D016660:NAD(P)H Dehydrogenase (Quinone); C447479:NQO1 protein, human